352 related articles for article (PubMed ID: 30125358)
1. Ethical considerations for modern molecular pathology.
Vos S; van Diest PJ; Ausems MG; van Dijk MR; de Leng WW; Bredenoord AL
J Pathol; 2018 Dec; 246(4):405-414. PubMed ID: 30125358
[TBL] [Abstract][Full Text] [Related]
2. [Unsolicited genomic findings in daily clinical practice].
Wouters RHP; Bijlsma RM; Voest EE; Bredenoord AL
Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040258
[TBL] [Abstract][Full Text] [Related]
3. Ethical and legal implications of whole genome and whole exome sequencing in African populations.
Wright GE; Koornhof PG; Adeyemo AA; Tiffin N
BMC Med Ethics; 2013 May; 14():21. PubMed ID: 23714101
[TBL] [Abstract][Full Text] [Related]
4. The value of cell-free DNA for molecular pathology.
Stewart CM; Kothari PD; Mouliere F; Mair R; Somnay S; Benayed R; Zehir A; Weigelt B; Dawson SJ; Arcila ME; Berger MF; Tsui DW
J Pathol; 2018 Apr; 244(5):616-627. PubMed ID: 29380875
[TBL] [Abstract][Full Text] [Related]
5. Unsolicited findings of next-generation sequencing for tumor analysis within a Dutch consortium: clinical daily practice reconsidered.
Bijlsma RM; Bredenoord AL; Gadellaa-Hooijdonk CG; Lolkema MP; Sleijfer S; Voest EE; Ausems MG; Steeghs N
Eur J Hum Genet; 2016 Oct; 24(10):1496-500. PubMed ID: 27071717
[TBL] [Abstract][Full Text] [Related]
6. The emerging significance of secondary germline testing in cancer genomics.
Mandelker D; Zhang L
J Pathol; 2018 Apr; 244(5):610-615. PubMed ID: 29293272
[TBL] [Abstract][Full Text] [Related]
7. The molecular pathology of cancer: from pan-genomics to post-genomics.
Huntsman DG; Ladanyi M
J Pathol; 2018 Apr; 244(5):509-511. PubMed ID: 29436707
[TBL] [Abstract][Full Text] [Related]
8. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
9. Guidance for laboratories performing molecular pathology for cancer patients.
Cree IA; Deans Z; Ligtenberg MJ; Normanno N; Edsjö A; Rouleau E; Solé F; Thunnissen E; Timens W; Schuuring E; Dequeker E; Murray S; Dietel M; Groenen P; Van Krieken JH; ;
J Clin Pathol; 2014 Nov; 67(11):923-31. PubMed ID: 25012948
[TBL] [Abstract][Full Text] [Related]
10. [Ethical dilemmas in a general practitioner's clinic due to incidental findings resulting from whole genome sequencing].
Wouters RHP; Bijlsma RM; Voest EE; Bredenoord AL
Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 31035742
[TBL] [Abstract][Full Text] [Related]
11. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.
McAlpine J; Leon-Castillo A; Bosse T
J Pathol; 2018 Apr; 244(5):538-549. PubMed ID: 29344951
[TBL] [Abstract][Full Text] [Related]
12. Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
Mandelker D; Zhang L; Kemel Y; Stadler ZK; Joseph V; Zehir A; Pradhan N; Arnold A; Walsh MF; Li Y; Balakrishnan AR; Syed A; Prasad M; Nafa K; Carlo MI; Cadoo KA; Sheehan M; Fleischut MH; Salo-Mullen E; Trottier M; Lipkin SM; Lincoln A; Mukherjee S; Ravichandran V; Cambria R; Galle J; Abida W; Arcila ME; Benayed R; Shah R; Yu K; Bajorin DF; Coleman JA; Leach SD; Lowery MA; Garcia-Aguilar J; Kantoff PW; Sawyers CL; Dickler MN; Saltz L; Motzer RJ; O'Reilly EM; Scher HI; Baselga J; Klimstra DS; Solit DB; Hyman DM; Berger MF; Ladanyi M; Robson ME; Offit K
JAMA; 2017 Sep; 318(9):825-835. PubMed ID: 28873162
[TBL] [Abstract][Full Text] [Related]
13. An ethical imperative: genetics education for physicians and patients.
Kegley JA
Med Law; 2003; 22(2):275-83. PubMed ID: 12889647
[TBL] [Abstract][Full Text] [Related]
14. Views of American OB/GYNs on the ethics of prenatal whole-genome sequencing.
Bayefsky MJ; White A; Wakim P; Hull SC; Wasserman D; Chen S; Berkman BE
Prenat Diagn; 2016 Dec; 36(13):1250-1256. PubMed ID: 27862072
[TBL] [Abstract][Full Text] [Related]
15. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
[TBL] [Abstract][Full Text] [Related]
16. PanCancer insights from The Cancer Genome Atlas: the pathologist's perspective.
Cooper LA; Demicco EG; Saltz JH; Powell RT; Rao A; Lazar AJ
J Pathol; 2018 Apr; 244(5):512-524. PubMed ID: 29288495
[TBL] [Abstract][Full Text] [Related]
17. Ethical, legal, and counseling challenges surrounding the return of genetic results in oncology.
Lolkema MP; Gadellaa-van Hooijdonk CG; Bredenoord AL; Kapitein P; Roach N; Cuppen E; Knoers NV; Voest EE
J Clin Oncol; 2013 May; 31(15):1842-8. PubMed ID: 23589552
[TBL] [Abstract][Full Text] [Related]
18. Ethical considerations of genetic testing.
Fleming DA
J Clin Ethics; 2002; 13(4):316-23. PubMed ID: 12793324
[No Abstract] [Full Text] [Related]
19. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
[TBL] [Abstract][Full Text] [Related]
20. The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology.
Matias-Guiu X; Stanta G; Carneiro F; Ryska A; Hoefler G; Moch H;
Virchows Arch; 2020 Apr; 476(4):491-497. PubMed ID: 32124002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]